We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PRME market cap is 693.78M. The company's latest EPS is USD -1.6507 and P/E is -3.50.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 591k |
| Operating Income | -40.03M | -45.26M | -51.46M | -68.04M | -48.34M |
| Net Income | -39.4M | -42.39M | -50.71M | -65.64M | -45.76M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.21M | 0 | 0 | 0 |
| Operating Income | -932k | -84.47M | -116.54M | -204.79M |
| Net Income | -5.06M | -184.12M | -142.01M | -198.13M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 316.95M | 280.87M | 239.15M | 193.85M | 311.38M |
| Total Liabilities | 38.15M | 40.76M | 45.19M | 60.78M | 67.62M |
| Total Equity | 278.8M | 240.1M | 193.96M | 133.07M | 243.77M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.78M | 301.86M | 360.31M | 193.85M |
| Total Liabilities | 21.31M | 62.3M | 44.04M | 60.78M |
| Total Equity | 2.34M | -156.24M | 316.27M | 133.07M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -41.56M | -82.38M | -121.55M | -165.41M | -67.71M |
| Investing | -12.67M | 15.2M | -22.57M | 18.71M | -37.03M |
| Financing | 68k | 143k | 461k | 655k | 157.33M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.54M | -34.08M | -131.83M | -165.41M |
| Investing | -1.06M | -73.63M | -47.1M | 18.71M |
| Financing | 34.93M | 269.28M | 181.49M | 655k |
| Market Cap | 693.78M |
| Price to Earnings Ratio | -3.50 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 16.66 |
| Price to Book Ratio | 5.2 |
| Dividend Yield | - |
| Shares Outstanding | 120.03M |
| Average Volume (1 week) | 720.8k |
| Average Volume (1 Month) | 1.02M |
| 52 Week Change | -61.44% |
| 52 Week High | 15.47 |
| 52 Week Low | 4.11 |
| Spread (Intraday) | 0.1 (1.72%) |
| Company Name | Prime Medicine Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.primemedicine.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
